1Pauwels RA,Buist AS,Calverley PM,et al. Global strategy for the diagnosis, management, and prevention of chronic obstructive pulmonary disease. NHLBI/WHO Global Initiative for Chronic Obstructive Lung Disease (GOLD) Workshop summary[J]. Am J Respir Crit Care Med, 2001,163(5) : 1256- 1276.
2Pauwets RA,Rabe KF. Burden and clinical features of chronic obstructive pulmonary disease (COPD) [J]. Lancet, 2004,364 (9434) ; 613-620.
4Demedts IK, Brusselle GG, Bracke KR, et al. Matrix metalloproteinases in asthma and COPD [J ]. Curt Opin Pharmacol, 2005,5 (3) : 257-263.
5Segura-Valdez L, Pardo A, Gaxiola M, et al. Upregulation of gelatinases A and B, collagenases 1 and 2, and increased parenehymal cell death in COPD[J]. Chest, 2000,117 (3) : 684- 694.
6Imai K, Mercer BA, Schulman LL,Sonett JR, et al. Correlation of lung surface area to apoptosis and proliferation in human emphysema[J]. Eur Respir J, 2005,25(2) :250-258.
7Yokohori N,Aoshiba K,Nagai A. Increased levels of cell death and proliferation in alveolar wall eells in patients with pulmonary emphysema[J]. Chest, 2004,125 (2) : 626-632.
8Hodge S, Hodge G, Holmes M, et al. Increased airway epithelial and T-cell apoptosis in COPD remains despite smoking cessation[J]. Eur Respir J, 2005,25 (3) : 447-454.
9Majo J, Ghezzo H, Cosio MG. Lymphocyte population and apoptosis in the lungs of smokers and their relation to emphysema[J]. Eur Respir J,2001,17(5) :946-953.
10Kasahara Y ,Tuder RM, Cool CD, et at. Endothelial cell death and decreased expression of vascular endothelial growth factor and vascular endothelial growth factor receptor 2 in emphysema[J]. Am J Respir Crit Care Med, 2001,163 (3 PT 1) : 737-744.
